Sales rise 46.67% to Rs 2532.61 crore
Net profit of Sun Pharmaceuticals Industries reported to Rs 259.39 crore in the quarter ended June 2018 as against net loss of Rs 1288.40 crore during the previous quarter ended June 2017. Sales rose 46.67% to Rs 2532.61 crore in the quarter ended June 2018 as against Rs 1726.70 crore during the previous quarter ended June 2017. ParticularsQuarter EndedJun. 2018Jun. 2017% Var.Sales2532.611726.70 47 OPM %19.98-9.73 -PBDT400.79-225.57 LP PBT259.60-335.20 LP NP259.39-1288.40 LPPowered by Capital Market - Live News
Disclaimer: No Business Standard Journalist was involved in creation of this content
